目次

Table of Contents

Executive Summary

Market Overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
Five Forces Summary
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Application
Market segments
Comparison by Application
Antiviral - Market size and forecast 2020-2025
Antibacterial - Market size and forecast 2020-2025
Antifungal - Market size and forecast 2020-2025
Antiparasitic - Market size and forecast 2020-2025
Market opportunity by Application

Customer landscape

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity by geography
Market drivers
Market challenges
Market trends

Vendor Landscape
Vendor landscape
Landscape disruption

Vendor Analysis
Vendors covered
Market positioning of vendors
AbbVie Inc.
CSL Ltd.
F. Hoffmann La Roche Ltd.
Gilead Sciences Inc.
GlaxoSmithKline Plc
Johnson and Johnson
Merck and Co. Inc.
Novartis AG
Pfizer Inc.
Sanofi SA

Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2020 - 2025 ($ billion)
13: Global market: Year-over-year growth 2020 - 2025 (%)
14: Five forces analysis 2020 & 2025
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2020
21: Application - Market share 2020-2025 (%)
22: Comparison by Application
23: Antiviral - Market size and forecast 2020-2025 ($ billion)
24: Antiviral - Year-over-year growth 2020-2025 (%)
25: Antibacterial - Market size and forecast 2020-2025 ($ billion)
26: Antibacterial - Year-over-year growth 2020-2025 (%)
27: Antifungal - Market size and forecast 2020-2025 ($ billion)
28: Antifungal - Year-over-year growth 2020-2025 (%)
29: Antiparasitic - Market size and forecast 2020-2025 ($ billion)
30: Antiparasitic - Year-over-year growth 2020-2025 (%)
31: Market opportunity by Application
32: Customer landscape
33: Market share by geography 2020-2025 (%)
34: Geographic comparison
35: North America - Market size and forecast 2020-2025 ($ billion)
36: North America - Year-over-year growth 2020-2025 (%)
37: Europe - Market size and forecast 2020-2025 ($ billion)
38: Europe - Year-over-year growth 2020-2025 (%)
39: Asia - Market size and forecast 2020-2025 ($ billion)
40: Asia - Year-over-year growth 2020-2025 (%)
41: ROW - Market size and forecast 2020-2025 ($ billion)
42: ROW - Year-over-year growth 2020-2025 (%)
43: Key leading countries
44: Market opportunity by geography ($ billion)
45: Impact of drivers and challenges
46: Vendor landscape
47: Landscape disruption
48: Industry risks
49: Vendors covered
50: Market positioning of vendors
51: AbbVie Inc. - Overview
52: AbbVie Inc. - Product and service
53: AbbVie Inc. - Key offerings
54: AbbVie Inc. - Key customers
55: AbbVie Inc. - Segment focus
56: CSL Ltd. - Overview
57: CSL Ltd. - Business segments
58: CSL Ltd. - Key offerings
59: CSL Ltd. - Key customers
60: CSL Ltd. - Segment focus
61: F. Hoffmann La Roche Ltd. - Overview
62: F. Hoffmann La Roche Ltd. - Business segments
63: F. Hoffmann La Roche Ltd. - Key offerings
64: F. Hoffmann La Roche Ltd. - Key customers
65: F. Hoffmann La Roche Ltd. - Segment focus
66: Gilead Sciences Inc. - Overview
67: Gilead Sciences Inc. - Product and service
68: Gilead Sciences Inc. - Key offerings
69: Gilead Sciences Inc. - Key customers
70: Gilead Sciences Inc. - Segment focus
71: GlaxoSmithKline Plc - Overview
72: GlaxoSmithKline Plc - Business segments
73: GlaxoSmithKline Plc - Key offerings
74: GlaxoSmithKline Plc - Key customers
75: GlaxoSmithKline Plc - Segment focus
76: Johnson and Johnson - Overview
77: Johnson and Johnson - Business segments
78: Johnson and Johnson - Key offerings
79: Johnson and Johnson - Key customers
80: Johnson and Johnson - Segment focus
81: Merck and Co. Inc. - Overview
82: Merck and Co. Inc. - Business segments
83: Merck and Co. Inc. - Key offerings
84: Merck and Co. Inc. - Key customers
85: Merck and Co. Inc. - Segment focus
86: Novartis AG - Overview
87: Novartis AG - Business segments
88: Novartis AG - Key offerings
89: Novartis AG - Key customers
90: Novartis AG - Segment focus
91: Pfizer Inc. - Overview
92: Pfizer Inc. - Business segments
93: Pfizer Inc. - Key offerings
94: Pfizer Inc. - Key customers
95: Pfizer Inc. - Segment focus
96: Sanofi SA - Overview
97: Sanofi SA - Business segments
98: Sanofi SA - Key offerings
99: Sanofi SA - Key customers
100: Sanofi SA - Segment focus
101: Currency conversion rates for US$
102: Research Methodology
103: Validation techniques employed for market sizing
104: Information sources
105: List of abbreviations